UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3800-3806

2013

Link zum Volltext

Verfügbarkeit prüfen

Genomic modeling of hepatitis B virus integration frequency in the human genome

PloS one, 2019-07, Vol.14 (7), p.e0220376-e0220376

2019

Link zum Volltext

Verfügbarkeit prüfen

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

The lancet oncology, 2010-03, Vol.11 (3), p.275-280

2010

Link zum Volltext

Verfügbarkeit prüfen

Linking hospital discharge and death records—accuracy and sources of bias

Journal of clinical epidemiology, 2004-01, Vol.57 (1), p.21-29

2004

Link zum Volltext

Verfügbarkeit prüfen

Sliced inverse moment regression using weighted chi-squared tests for dimension reduction

Journal of statistical planning and inference, 2010-11, Vol.140 (11), p.3121-3131

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4840-4847

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer

Cancer, 2005-12, Vol.104 (11), p.2449-2456

2005

Link zum Volltext

Verfügbarkeit prüfen

Knowledge of Antiretroviral Regimen Dosing and Adherence: A Longitudinal Study

Clinical infectious diseases, 2003-02, Vol.36 (4), p.514-518

2003

Link zum Volltext

Verfügbarkeit prüfen

The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection

Journal of hepatology, 2015-08, Vol.63 (2), p.320-328

2015

Link zum Volltext

Verfügbarkeit prüfen

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

Lung cancer (Amsterdam, Netherlands), 2007-02, Vol.55 (2), p.187-194

2007

Link zum Volltext

Verfügbarkeit prüfen

Information-based group sequential design for post-market safety monitoring of medical products using real world data

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trial

Lung cancer (Amsterdam, Netherlands), 2006-07, Vol.53 (1), p.77-83

2006

Link zum Volltext

Verfügbarkeit prüfen

SAT-191-Host genome integration of hepatitis B is prolific and is the primary contributor to viral HBs antigen gene expression

Journal of hepatology, 2019-04, Vol.70 (1), p.e714-e714

2019

Link zum Volltext

Verfügbarkeit prüfen

Controlling alpha for mixed effects models for repeated measures

Journal of biopharmaceutical statistics, 2018-11, Vol.28 (6), p.1055-1077

2018

Link zum Volltext

Verfügbarkeit prüfen

A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer

Urologic oncology, 2004-09, Vol.22 (5), p.393-397

2004

Link zum Volltext

Verfügbarkeit prüfen

Using the Bootstrap to Select One of a New Class of Dimension Reduction Methods

Journal of the American Statistical Association, 2003-12, Vol.98 (464), p.968-979

2003

Link zum Volltext

Verfügbarkeit prüfen

Denosumab in castration-resistant prostate cancer – Authors' reply

The Lancet (British edition), 2012-05, Vol.379 (9828), p.e50-e51

2012

Link zum Volltext

Verfügbarkeit prüfen

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

Clinical lung cancer, 2005-07, Vol.7 (1), p.40-46

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of denosumab on prolonging bone-metastasis free survival (BMFS) in men with nonmetastatic castrate-resistant prostate cancer (CRPC) presenting with aggressive PSA kinetics

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4510-4510

2012

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program

Journal of thoracic oncology, 2006-07, Vol.1 (6), p.506-512

2006

Link zum Volltext

Verfügbarkeit prüfen

Denosumab and bone-metastasis-free survival in men with @ castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

The Lancet (British edition), 2012, Vol.379 (9810), p.39-46

2012

Link zum Volltext

Verfügbarkeit prüfen

Denosumab and Bone Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Global Phase 3, Randomised, Placebo-Controlled Trial

The Lancet (British edition), 2011-11, Vol.379 (9810), p.39-46

2011

Link zum Volltext

Verfügbarkeit prüfen

The Research of Value Chain Operation Model in E-commerce

2008 International Seminar on Business and Information Management, 2008, Vol.1, p.238-241

2008

Link zum Volltext
Volltext

Neoadjuvant Chemotherapy with Gemcitabine-Containing Regimens in Patients with Early-Stage Non-small Cell Lung Cancer

Journal of thoracic oncology, 2008-01, Vol.3 (1), p.37-45

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(41)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Humans
(22)
Life Sciences & Biomedicine
(22)
Aged
(17)
Female
(15)
Male
(15)
Middle Aged
(15)
Adult
(14)
Oncology
(13)
Treatment Outcome
(12)
Aged, 80 And Over
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Disease Progression
(7)
Glutamates - Administration & Dosage
(7)
Guanine - Administration & Dosage
(7)
Guanine - Analogs & Derivatives
(7)
Pemetrexed
(7)
Survival Analysis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

Genomic modeling of hepatitis B virus integration frequency in the human genome

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

Linking hospital discharge and death records—accuracy and sources of bias

Sliced inverse moment regression using weighted chi-squared tests for dimension reduction

Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer

Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer

Knowledge of Antiretroviral Regimen Dosing and Adherence: A Longitudinal Study

The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

Information-based group sequential design for post-market safety monitoring of medical products using real world data

Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trial

SAT-191-Host genome integration of hepatitis B is prolific and is the primary contributor to viral HBs antigen gene expression

Controlling alpha for mixed effects models for repeated measures

A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer

Using the Bootstrap to Select One of a New Class of Dimension Reduction Methods

Denosumab in castration-resistant prostate cancer – Authors' reply

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

Effect of denosumab on prolonging bone-metastasis free survival (BMFS) in men with nonmetastatic castrate-resistant prostate cancer (CRPC) presenting with aggressive PSA kinetics

Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program

Denosumab and bone-metastasis-free survival in men with @ castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Denosumab and Bone Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Global Phase 3, Randomised, Placebo-Controlled Trial

The Research of Value Chain Operation Model in E-commerce

Neoadjuvant Chemotherapy with Gemcitabine-Containing Regimens in Patients with Early-Stage Non-small Cell Lung Cancer

Suchergebnisse filtern